From Jaded CMIO: “Re your recent comments about the Medication Access and Training Expansion Act (MATE) and its 8-hour DEA education requirement being a time waster. I’m in the same boat – I don’t…
Continue Reading
Truveris, a health technology company focused on decreasing prescription costs for employers and their members, announced it secured $15 million in Series E investment. Existing investors Canaan Partners and New Leaf Venture Partners led the…
Continue Reading
By Anuja Vaidya
March 06, 2024 – Regulatory flexibilities enabling virtual initiation and at-home doses of medications for opioid use disorder (OUD) are likely cost-effective, according to new research.
Published in the journal Drug and Alcohol Dependence,…
Continue Reading
By Sara Heath
December 15, 2023 – About a million Medicare enrollees have opioid use disorder (OUD), but only 18 percent of them received medication to treat OUD, according to a new Office of Inspector General…
Continue Reading
Walgreens and RxSense partner to unveil Rx Savings Finder, a digital platform aiding consumers in accessing discounted prescription drugs via third-party cards. Utilizing RxSense’s technology, this tool offers free coupons without subscription fees, combinable…
Continue Reading
Walgreens is collaborating with medication access and transparency technology company RxSense to launch a digital marketplace, Rx Savings Finder, where consumers can save money on medication by comparing prices on free third-party discount prescription…
Continue Reading
By Anuja Vaidya
November 06, 2023 – A bipartisan group of four senators reintroduced legislation that would eliminate barriers to the virtual prescription of medication for opioid use disorder (OUD).
Called the Telehealth Response for E-prescribing Addiction…
Continue Reading
Surviving the Blizzard: How Technology Can Ease Specialty Medication Re-Enrollment SeasonBy Julia Regan
Julia Regan, MBA is founder and CEO of RxLightning of New Albany, IN.
One of the most challenging times of the year for…
Continue Reading
Specialty medications are often used to treat complex diseases, many times in life-saving situations. But the robust process to onboard a patient on a specialty medication highlights an urgent need to modernize healthcare technology,…
Continue Reading
LRVHealth, McKesson Ventures, Novartis, Hearst Ventures, Onco360, and HealthX Ventures Join Investment Round to Redefine Specialty Patient Access and Onboarding
RxLightning, creator of the industry’s first comprehensive platform for streamlining specialty medication access and affordability,…
